The Truth About Skin Care

Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today the commercial launch of VIBATIV™ (telavancin) in the United States. On September 11, 2009, the U.S. Food and Drug Administration (FDA) approved VIBATIV for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus [...]

Onset Therapeutics, a specialty pharmaceutical company focused in dermatology, announced the FDA approval and commercial launch of HYLATOPIC™ Emollient Foam, a unique, non-steroidal prescription product indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including atopic dermatitis, allergic contact dermatitis and radiation dermatitis.

Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur.

Pale skinned people who are most at risk of skin cancer are ignoring sun safety advice, according to research released today to launch Sun Awareness Week 2009. The survey of 1500 UK adults looked at people’s behaviour in the sun in relation to their individual risk of skin cancer, as well [...]

Incisive Surgical, Inc. announced that it will launch a significantly more user-friendly next generation version of its INSORB Absorbable Skin Stapler at the Annual Meeting of the American College of Obstetricians & Gynecologists being held in Chicago from May 4 – 6, 2009. The INSORB(R)|25 Skin Stapler is a patented medical device that places an [...]